Yinglong Zhang
569 Xinsi Road
Xi'an, 710038, China
Xi'an, 710038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
C/EBP alpha agonist ICCB280 overcomes doxorubicin resistance in osteosarcoma through mitochondrial dynamics-dependent GREM1-MAPK activation.
Journal: Cell death & disease
Published: November 10, 2025
Co-Delivery of Cisplatin and Curcumin via ROS-Responsive Nanoparticles to Activate the cGAS-STING Pathway for Osteosarcoma Metalloimmunotherapy.
Journal: Advanced healthcare materials
Published: September 15, 2025
LINC00673 promotes osteosarcoma progression through the miR-92b-3p/DUSP1 axis.
Journal: Pathology, research and practice
Published: September 02, 2025
Unveiling the role of the extracellular matrix in the osteosarcoma tumor microenvironment through integrated transcriptomics and experimental validation.
Journal: Cancer gene therapy
Published: April 06, 2025
RNF135 Promotes Human Osteosarcoma Cell Growth and Inhibits Apoptosis by Upregulating the PI3K/AKT Pathway.
Journal: Cancer reports (Hoboken, N.J.)
Published: February 10, 2024
Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
Journal: Gene
Published: November 15, 2023
GRM4 inhibits the proliferation, migration, and invasion of human osteosarcoma cells through interaction with CBX4.
Journal: Bioscience, biotechnology, and biochemistry
Published: October 05, 2019
Use Of Microwave Thermal Ablation In Management Of Skip Metastases In Extremity Osteosarcomas.
Journal: Cancer management and research
Published: July 04, 2019
Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma.
Journal: Theranostics
Published: January 25, 2019
Self-seeding circulating tumor cells promote the proliferation and metastasis of human osteosarcoma by upregulating interleukin-8.
Journal: Cell death & disease
Published: October 10, 2018
Hypoxia promotes chemotherapy resistance by down-regulating SKA1 gene expression in human osteosarcoma.
Journal: Cancer biology & therapy
Published: March 10, 2017
Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation.
Journal: Cell cycle (Georgetown, Tex.)
Published: July 19, 2016
Last Updated: 09/26/2026